Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2168.20 | 459 / 459 | 100% | 33.92 | 1118 / 1118 |
esophagus | 100% | 2759.90 | 1445 / 1445 | 100% | 25.60 | 183 / 183 |
intestine | 100% | 3129.37 | 966 / 966 | 100% | 35.23 | 527 / 527 |
liver | 100% | 2432.25 | 226 / 226 | 100% | 28.10 | 406 / 406 |
ovary | 100% | 2213.58 | 180 / 180 | 100% | 28.31 | 430 / 430 |
prostate | 100% | 2439.47 | 245 / 245 | 100% | 29.56 | 502 / 502 |
stomach | 100% | 2313.26 | 359 / 359 | 100% | 30.79 | 286 / 286 |
uterus | 100% | 2481.36 | 170 / 170 | 100% | 35.87 | 459 / 459 |
thymus | 100% | 2470.59 | 653 / 653 | 100% | 26.26 | 604 / 605 |
lung | 100% | 2363.33 | 577 / 578 | 100% | 32.29 | 1155 / 1155 |
skin | 100% | 2763.34 | 1809 / 1809 | 100% | 29.61 | 471 / 472 |
brain | 100% | 2290.58 | 2633 / 2642 | 100% | 26.70 | 705 / 705 |
kidney | 100% | 3077.15 | 89 / 89 | 100% | 28.65 | 897 / 901 |
bladder | 100% | 2514.24 | 21 / 21 | 99% | 31.57 | 501 / 504 |
pancreas | 100% | 1382.44 | 327 / 328 | 99% | 31.07 | 177 / 178 |
adrenal gland | 100% | 2596.17 | 258 / 258 | 99% | 20.16 | 228 / 230 |
adipose | 100% | 2289.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 43.55 | 29 / 29 |
muscle | 100% | 4871.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2930.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.90 | 1 / 1 |
blood vessel | 100% | 2474.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1773.76 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 19.24 | 78 / 80 |
peripheral blood | 96% | 2419.57 | 895 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060339 | Biological process | negative regulation of type I interferon-mediated signaling pathway |
GO_0006413 | Biological process | translational initiation |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_0045947 | Biological process | negative regulation of translational initiation |
GO_0017148 | Biological process | negative regulation of translation |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0016281 | Cellular component | eukaryotic translation initiation factor 4F complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0000339 | Molecular function | RNA cap binding |
GO_0008135 | Molecular function | translation factor activity, RNA binding |
GO_0098808 | Molecular function | mRNA cap binding |
GO_0000340 | Molecular function | RNA 7-methylguanosine cap binding |
GO_0005515 | Molecular function | protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF4E2 |
Protein name | Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3) Eukaryotic translation initiation factor 4E family member 2 (cDNA FLJ59146, moderately similar to Eukaryotic translation initiation factor 4E type 3) Eukaryotic translation initiation factor 4E member 2, isoform CRA_c (cDNA FLJ12456 fis, clone NT2RM1000661, highly similar to Eukaryotic translation initiation factor 4E type 3) Eukaryotic translation initiation factor 4E family member 2 |
Synonyms | tmp_locus_9 hCG_33450 EIF4EL3 |
Description | FUNCTION: Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation. Acts as a repressor of translation initiation . In contrast to EIF4E, it is unable to bind eIF4G (EIF4G1, EIF4G2 or EIF4G3), suggesting that it acts by competing with EIF4E and block assembly of eIF4F at the cap (By similarity). In P-bodies, component of a complex that promotes miRNA-mediated translational repression . Involved in virus-induced host response by mediating miRNA MIR34A-induced translational silencing which controls IFNB1 production by a negative feedback mechanism . .; FUNCTION: Component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation . In association with GIGYF2, assists ribosome-associated quality control (RQC) by sequestering the mRNA cap, blocking ribosome initiation and decreasing the translational load on problematic messages. Part of a pathway that works in parallel to RQC-mediated degradation of the stalled nascent polypeptide. GIGYF2 and EIF4E2 work downstream and independently of ZNF598, which seems to work as a scaffold that can recruit them to faulty mRNA even if alternative recruitment mechanisms may exist . .; FUNCTION: (Microbial infection) Upon SARS coronavirus-2/SARS-CoV-2 infection, the interaction with non-structural protein 2 (nsp2) with GIGYF2 enhances GIGYF2 binding to EIF4E2 and increases repression of translation initiation of genes involved in antiviral innate immune response such as IFNB1. . |
Accessions | ENST00000258416.8 [O60573-1] O60573 Q53RG0 B8ZZ50 ENST00000690794.1 H7BZH2 B9A044 A0A8I5KSA5 B8ZZL3 ENST00000409495.6 ENST00000454501.1 A0A8I5KT16 ENST00000409167.8 ENST00000409322.5 ENST00000444113.1 B9A023 C9JEL3 ENST00000409394.5 ENST00000409514.5 B4E1E4 ENST00000409098.5 [O60573-2] ENST00000687222.1 |